"Rising Demand, Short Supply: The Ongoing Challenge of ADHD Medication Availability"

Shortages of ADHD medications, including Adderall, have caused strain on patients and families, with some experiencing delays of weeks or months in obtaining refills, impacting children's ability to function in school. The shortage is attributed to supply constraints, manufacturing problems, and increased demand during the pandemic, with prescriptions for ADHD treatments accelerating, particularly among young people and women. The pharmaceutical industry faces challenges in production and sourcing, leading to difficulties in finding alternative medications and impacting the healthcare system, pharmacies, patients, and providers.